Location History:
- Prague, CZ (2011)
- Klinec, CZ (2013 - 2015)
Company Filing History:
2 out of 20 
1 out of 5 
1 out of 2 Years Active: 2011-2015
Title: Innovations in Cancer Treatment by Inventor Tomas Etrych
Introduction
Tomas Etrych, an accomplished inventor based in Klinec, Czech Republic, is renowned for his significant contributions to the field of biomedicine, particularly in cancer treatment. With a total of three patents to his name, Etrych's work focuses on developing innovative polymer drug carriers that enhance the effectiveness of anticancer therapies.
Latest Patents
Etrych's latest innovations include groundbreaking patents that revolve around dendritic high-molecular-weight polymer drug carriers specifically designed for the targeted treatment of solid tumors. His first patent details the creation of water-soluble high-molecular-weight polymer drug carriers and their conjugates with drugs, derived from dendrimers of the amidoamine and 2,2-bis(hydroxymethyl)propanoic types. These polymer carriers facilitate targeted transport of anticancer drugs, ensuring controlled drug release and improved biodegradation for effective tumor treatment.
Furthermore, Etrych has developed grafted macromolecular conjugates of doxorubicin that exhibit anticancer activity. This invention utilizes a water-soluble polymeric carrier formed from N-(2-hydroxypropyl)methacrylamide copolymer, effectively binding the drug via hydrolytically cleavable hydrazone bond spacers. This method of preparation enhances the delivery and effectiveness of the anticancer agent within the human body.
Career Highlights
Throughout his career, Tomas Etrych has held roles at prominent institutions, most notably at Zentiva and the Institute of Macromolecular Chemistry, Czech Academy of Sciences. These affiliations have provided him with a solid foundation in both practical and research environments, allowing him to refine his innovative approaches to drug development.
Collaborations
Etrych has had the privilege of working alongside notable colleagues in the field, including Karel Ulbrich and Blanka Rihova. Their collaborations have undoubtedly contributed to the advancements in his research, fostering an environment of shared knowledge and innovation.
Conclusion
In conclusion, Tomas Etrych stands out as a leading inventor whose work has the potential to revolutionize cancer treatment through innovative polymer drug carriers. His patents reflect a commitment to advancing medical technology, ensuring targeted and effective therapies for patients suffering from solid tumors. Through collaborations and a strong career foundation, Etrych continues to pave the way for future innovations in the biomedical field.